Green-top Guideline No. 74: Antenatal corticosteroids to reduce neonatal morbidity and mortality
You can access the Green-top Guideline No. 74: Antenatal corticosteroids to reduce neonatal morbidity and mortality tutorial for just £20.00 . UK prices shown, other nationalities may qualify for reduced prices. If this tutorial is part of the member benefit package, Fellows, Members, registered Trainees and Associates should sign in to access the tutorial. Non-members can purchase access to tutorials but also need to sign in first. New users can register here.
Welcome to this tutorial on Antenatal corticosteroids to reduce neonatal morbidity and mortality (Green-top Guideline No. 74)
Maternal administration of antenatal corticosteroids before anticipated preterm birth is one of the most important interventions to improve neonatal outcomes.
They are effective in reducing neonatal respiratory morbidity and other complications of prematurity.
The aim of this guideline is to provide evidence-based recommendations on the use of antenatal corticosteroids in women at risk of preterm birth or undergoing caesarean birth at term.
View the full guideline: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/antenatal-corticosteroids-to-reduce-neonatal-morbidity-and-mortality-green-top-guideline-no-74/